Tricida, Inc. Gains 38.72%
Tricida, Inc. (TCDA:NASDAQ) jumped higher at $0.28, a gain of 38.7%. On Mon, Nov 28, 2022, TCDA:NASDAQ touched a New 2-Week High of $0.28. The stock got featured on our News Catalysts scanner on Wed, Nov 16, 2022 at 02:16 PM in the 'BIOTECH' category. From Mon, Nov 14, 2022, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Wed, Oct 12, 2022 at $13.12 with a volume of 1M+.
About Tricida, Inc. (TCDA:NASDAQ)
Tricida Inc is a late-stage pharmaceutical company. It is engaged in the development of novel therapeutics to address renal, metabolic and cardiovascular disease. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.
Top 10 Gainers:
- Taboola.com Ltd. (TBLA:NASDAQ), 43.48%
- Tricida, Inc. (TCDA:NASDAQ), 38.72%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 31.54%
- Biophytis SA (BPTS:NASDAQ), 30.01%
- Bit Brother Limited (BTB:NASDAQ), 28.83%
- GigaCloud Technology Inc (GCT:NASDAQ), 28.73%
- Nutex Health Inc. (NUTX:NASDAQ), 28.1%
- Katapult Holdings Inc. (KPLT:NASDAQ), 22.93%
- Lion Group Holding Ltd. (LGHL:NASDAQ), 22.81%
- Nogin Inc. (NOGN:NASDAQ), 22.51%